UK non invasive prenatal testing gestation period outlook (Revenue, USD million, 2018-2030)
- 0-12 weeks
- 13-24 weeks
- 25-36 weeks
UK non invasive prenatal testing risk outlook (Revenue, USD million, 2018-2030)
- High & Average Risk
- Low Risk
UK non invasive prenatal testing method outlook (Revenue, USD million, 2018-2030)
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-Free DNA in Maternal Plasma Tests
UK non invasive prenatal testing technology outlook (Revenue, USD million, 2018-2030)
- NGS
- Array Technology
- PCR
- Others
UK non invasive prenatal testing product outlook (Revenue, USD million, 2018-2030)
- Consumables & Reagents
- Instruments
UK non invasive prenatal testing application outlook (Revenue, USD million, 2018-2030)
- Trisomy
- Microdeletion Syndrome
- Other Applications
UK non invasive prenatal testing end-use outlook (Revenue, USD million, 2018-2030)
- Hospitals & Clinics
- Diagnostic Laboratories